Determining the duration of protection provided by coronavirus vaccines is particularly important in determining the vaccination schedule and making public health decisions.
The Doctors of the Therapeutic Clinic of the Medical School of the National and Kapodistrian University of Athens Theodora Psaltopoulou, Giannis Danasis, Panos Malandrakis and Thanos Dimopoulos (Rector of EKPA) summarize the latest data from the relevant publication of an article in the Lancet by DR Feikin et al. : https: //doi.org/10.1016/S0140-6736 (22) 00152-0).
The researchers conducted a systematic review and meta-analysis of all relevant articles in the literature from June 17, 2021 to December 2, 2021.
The studies included were randomized clinical trials and observational studies. A total of data from 18 studies, which were performed before the predominance of the Omicron strain, were included.
Based on the critical evaluation of the studies, the probability of error (bias) was judged low for the 3 studies, moderate for the 8 studies and severe for the 7 studies. 78 COVID-19 vaccine efficacy evaluations were performed, namely 38 for Cominarty vaccine (Pfizer / BioNTech), 23 for mRNA-1273 (Moderna), 9 for Ad26.COV2.S (Johnson) and 8 for Vaxzevria (AstraZeneca) .
After how long does the effectiveness of the vaccine decrease?
Overall, the efficacy of full vaccination against SARS-CoV-2 infection decreased at 21 months post-vaccination by 21% compared with efficacy at 1 month post-vaccination regardless of age.
In older vaccinated persons (over 50 years) efficacy over the same period decreased by 21%.
In addition, the efficacy of full vaccination against symptomatic COVID-19 disease was reduced at 25 months post-vaccination by 25% compared with efficacy at 1 month post-vaccination regardless of age. In older vaccinated persons (over 50 years of age) the efficacy against symptomatic COVID-19 was reduced by 32% over the same period.
In addition, the efficacy of full vaccination against severe COVID-19 disease decreased at 6 months post-vaccination by 10% compared with efficacy at 1 month post-vaccination regardless of age.
In older vaccinated (over 50 years) the efficacy against severe COVID-19 disease during the same period was also reduced by 10%. Overall, the efficacy of the vaccine against severe disease remained at levels above 70% over time up to 6 months after vaccination. Decreased efficacy of vaccines against SARS-CoV-2 infection can be attributed to the decline of immunity to the virus over time, as well as to the emergence and prevalence of new strains of the virus.
Latest News
Intrum’s 2024 Report Unveils Greek Businesses Embrace Digitalization for Growth
Looking ahead, over 40% of businesses prioritize development for 2024, with 65% recognizing the potential of digital business models as sustainable investments
IOBE: Mild Drop in April Business Confidence Index (BCI) in Greece
The positive balance of expectations for employment witnessed a marginal decline, while the index for production forecasts also recorded a mild drop
Greek PM Mitsotakis Calls on EU to Intervene Over Multinationals’ Pricing Policy
Speaking about price fairness, the Prime Minister emphasized, "Europe should also mean similar or uniform prices for the products sold by our multinational corporations.
Greenhouse Gas Emissions: 4% Decrease in EU, 0.3% Rise in Greece in Q4 2023
The EU's GDP remained stable with a marginal 0.2% increase in fourth quarter of 2023
HEREMA CEO: High Expectations from Natgas Exploration Off Crete
3D seismic surveys were conducted in the two offshore blocks west and southwest of Crete by a consortium comprised of ExxonMobil and HelleniQ Energy
EC Spring Forecast: Greek GDP at 2.2 in 2024, 2.3% in 2025
Besides Greek GDP inflation is expected to drop by a substantial 2.4% in 2024, settling at 2.8% from 4.2% in 2023 with 2025 recording a further decline to 2.1%
EBRD Raises Outlook for Greek GDP to 2.3% in 2024, 2.6% in 2025
Key downside risks remain, associated with possible delays in deploying Recovery and Resilience Facility (RRF) funds and weaknesses in key export markets and tourism source countries
Real Estate Insights: Athens’ Top Areas with the Highest Yields
In the first quarter of 2024, Korydallos in the Piraeus region and the burgeoning Attiki Square retain their top spots with impressive yields of 6.3%
ELSTAT: Inflation at 3.1% in April
Olive oil (63.7%), fruit (11.6%), fish (10.6%), and mineral water (12.5%) registered the highest increases annually
Greek Sunlight CEO Joins Industry Titans at Choose France Summit
At the heart of the "Choose France Summit" was the discussion surrounding the production of lead-acid and lithium-ion batteries, crucial for the green transition and storage of renewable energy.